Kelley Kenneth J 4
4 · HALOZYME THERAPEUTICS, INC. · Filed May 1, 2020
Insider Transaction Report
Form 4
Kelley Kenneth J
Director
Transactions
- Award
Common Stock
2020-04-30+8,829→ 286,382 total
Footnotes (1)
- [F1]Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) April 30, 2021 or (ii) the date of the Issuer's next annual meeting of stockholders.